Value for Money in Health Spending

image of Value for Money in Health Spending

Health spending continues to rise inexorably, growing faster than the economy in most OECD countries. Most of this spending comes from the public purse. Given the recent economic downturn, countries are looking for ways to improve the efficiency of health spending. This publication examines current efforts to improve health care efficiency, including tools that show promise in helping health systems provide the best care for their money, such as pay for performance, co-ordination of care, health technology assessment and clinical guidelines, pharmaceutical re-imbursement and risk-sharing agreements, and information and communication technology.

English French, Korean


Drawing all the Benefits from Pharmaceutical Spending

OECD countries’ pharmaceutical policies generally focus on three main objectives: making medicines accessible and affordable to patients; containing public spending growth, and providing incentives for future innovation. This chapter provides a brief review of current pharmaceutical reimbursement and pricing policies in OECD countries, as well as short-term measures adopted in response to the economic crisis. It then focuses in particular on two important issues: decisions pertaining to the coverage of new products with high costs and/or uncertain benefits, and the development of generic markets.

English French

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error